Insiders · Profile

Schwab Andrew J.

Director at Skye Bioscience · Director at Camp4 Therapeutics. Filing since 11 Sep 2024. CIK 0001598549

Company
Date
Role
Action
Shares
Amount
Of holding
23 Sep 2026
Director
Sold at will
114,851
$184.91K
100%
23 Sep 2026
Director
Sold at will
4,528
$7.29K
100%
22 Sep 2026
Director
Sold at will
27,612
$45.56K
19.4%
22 Sep 2026
Director
Sold at will
1,088
$1.80K
19.4%
16 Sep 2026
Director
Sold at will
32,607
$62.28K
18.6%
16 Sep 2026
Director
Sold at will
1,285
$2.45K
18.6%
27 Aug 2026
Director
Sold at will
400,000
$1.62M
16.4%
24 Aug 2026
Director
Sold at will
10
$45.00
0.0%
21 Aug 2026
Director
Sold at will
32,018
$144.08K
1.3%
20 Aug 2026
Director
Sold at will
114,700
$520.74K
4.4%
20 Aug 2026
Director
Sold at will
7,700
$2.46K
12.2%
19 Aug 2026
Director
Sold at will
45,147
$214.90K
1.7%
19 Aug 2026
Director
Sold at will
68,140
$23.85K
55.2%
18 Aug 2026
Director
Sold at will
300,000
$114.00K
84.3%
22 Aug 2025
Director
Sold at will
170,449
$582.94K
74.8%
21 Aug 2025
Director
Sold at will
60,956
$217.61K
48.8%
15 Oct 2024
Director
Bought
909,090
$10.00M
53.0%
13 Sep 2024
Director
Sold at will
13,837
$83.85K
17.3%
11 Sep 2024
Director
Sold at will
252,500
$1.67M
79.2%
19 decisions on file.